37288434|t|Mechanisms involved in hereditary angioedema with normal C1-inhibitor activity.
37288434|a|Patients with the inherited disorder hereditary angioedema (HAE) suffer from episodes of soft tissue swelling due to excessive bradykinin production. In most cases, dysregulation of the plasma kallikrein-kinin system due to deficiency of plasma C1 inhibitor is the underlying cause. However, at least 10% of HAE patients have normal plasma C1 inhibitor activity levels, indicating their syndrome is the result of other causes. Two mutations in plasma protease zymogens that appear causative for HAE with normal C1 inhibitor activity have been identified in multiple families. Both appear to alter protease activity in a gain-of-function manner. Lysine or arginine substitutions for threonine 309 in factor XII introduces a new protease cleavage site that results in formation of a truncated factor XII protein (Delta-factor XII) that accelerates kallikrein-kinin system activity. A glutamic acid substitution for lysine 311 in the fibrinolytic protein plasminogen creates a consensus binding site for lysine/arginine side chains. The plasmin form of the variant plasminogen cleaves plasma kininogens to release bradykinin directly, bypassing the kallikrein-kinin system. Here we review work on the mechanisms of action of the FXII-Lys/Arg309 and Plasminogen-Glu311 variants, and discuss the clinical implications of these mechanisms.
37288434	23	44	hereditary angioedema	Disease	MESH:D054179
37288434	80	88	Patients	Species	9606
37288434	98	138	inherited disorder hereditary angioedema	Disease	MESH:D054179
37288434	140	143	HAE	Disease	MESH:D054179
37288434	169	189	soft tissue swelling	Disease	MESH:D017695
37288434	207	217	bradykinin	Gene	3827
37288434	273	283	kallikrein	Gene	9622
37288434	304	337	deficiency of plasma C1 inhibitor	Disease	MESH:D054179
37288434	388	391	HAE	Disease	MESH:D054179
37288434	392	400	patients	Species	9606
37288434	575	578	HAE	Disease	MESH:D054179
37288434	725	775	Lysine or arginine substitutions for threonine 309	ProteinMutation	tmVar:p|SUB|T|309|K,R;HGVS:p.T309K,R;VariantGroup:2;CorrespondingGene:2161;CorrespondingSpecies:9606
37288434	779	789	factor XII	Gene	2161
37288434	871	881	factor XII	Gene	2161
37288434	926	936	kallikrein	Gene	9622
37288434	962	1003	glutamic acid substitution for lysine 311	ProteinMutation	tmVar:p|SUB|K|311|E;HGVS:p.K311E;VariantGroup:1;CorrespondingGene:5340;CorrespondingSpecies:9606
37288434	1032	1043	plasminogen	Gene	5340
37288434	1081	1096	lysine/arginine	ProteinMutation	tmVar:p|SUB|K||R;VariantGroup:0;CorrespondingGene:5340;CorrespondingSpecies:9606
37288434	1114	1121	plasmin	Gene	5340
37288434	1142	1153	plasminogen	Gene	5340
37288434	1191	1201	bradykinin	Gene	3827
37288434	1226	1236	kallikrein	Gene	9622
37288434	1306	1310	FXII	Gene	2161
37288434	1326	1337	Plasminogen	Gene	5340
37288434	Association	MESH:D054179	2161
37288434	Association	MESH:D054179	HGVS:p.T309K,R;CorrespondingGene:2161
37288434	Association	CorrespondingGene:5340;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p	HGVS:p.K311E;CorrespondingGene:5340
37288434	Association	MESH:D054179	HGVS:p.K311E;CorrespondingGene:5340
37288434	Association	3827	5340
37288434	Association	MESH:D054179	3827
37288434	Association	MESH:D054179	5340

